Autek China Inc. (SHE:300595)

Market Cap	10.65B -19.2%
Revenue (ttm)	1.84B +0.8%
Net Income	465.44M -13.7%
EPS	0.52 -13.6%
Shares Out	895.29M
PE Ratio	22.81
Forward PE	15.78
Dividend	0.15 (1.26%)
Ex-Dividend Date	May 20, 2026

Volume	8,510,198
Open	12.74
Previous Close	12.08
Day's Range	11.76 - 12.74
52-Week Range	11.78 - 19.98
Beta	0.68
Analysts	Hold
Price Target	16.28 (+36.81%)
Earnings Date	Aug 20, 2026

About Autek China

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices. Autek China Inc. was incorporated in 2000 and is based in Hefei, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 3,752
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300595

Financial Performance

In 2025, Autek China's revenue was 1.86 billion, an increase of 2.62% compared to the previous year's 1.81 billion. Earnings were 479.52 million, a decrease of -16.20%.